Atreca, Inc.

Atreca, Inc.verified

BCEL

Price:

$0.09

Market Cap:

$3.57M

Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria...[Read more]

Industry

Biotechnology

IPO Date

2019-06-20

Stock Exchange

NASDAQ

Ticker

BCEL

The ROE as of December 2024 (TTM) for Atreca, Inc. (BCEL) is -199.88%

According to Atreca, Inc.’s latest financial reports and current stock price. The company's current ROE is -199.88%. This represents a change of 82.96% compared to the average of -109.25% of the last 4 quarters.

Atreca, Inc. (BCEL) Historical ROE (quarterly & annually)

How has BCEL ROE performed in the past?

The mean historical ROE of Atreca, Inc. over the last ten years is -40.26%. The current -199.88% ROE has changed 396.51% with respect to the historical average. Over the past ten years (40 quarters), BCEL's ROE was at its highest in in the March 2018 quarter at 0%. The ROE was at its lowest in in the September 2023 quarter at -336.60%.

Quarterly (TTM)
Annual

Average

-40.26%

Median

-35.88%

Minimum

-115.46%

Maximum

48.66%

Atreca, Inc. (BCEL) ROE by Quarter and Year

Discovering the peaks and valleys of Atreca, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 97.84%

Maximum Annual ROE = 48.66%

Minimum Annual Increase = -166.63%

Minimum Annual ROE = -115.46%

Quarterly (TTM)
Annual
YearROEChange
2022-115.46%63.62%
2021-70.57%97.84%
2020-35.67%-1.19%
2019-36.10%11.33%
2018-32.42%-166.63%

Atreca, Inc. (BCEL) Average ROE

How has BCEL ROE performed in the past?

The current ROE of Atreca, Inc. (BCEL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-73.90%

5-year avg

-58.04%

10-year avg

-40.26%

Atreca, Inc. (BCEL) ROE vs. Peers

How is BCEL’s ROE compared to its peers?

Atreca, Inc.’s ROE is greater than Passage Bio, Inc. (-72.53%), greater than Homology Medicines, Inc. (-100.91%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than TCR2 Therapeutics Inc. (-71.90%), greater than Revolution Medicines, Inc. (-33.67%), greater than Black Diamond Therapeutics, Inc. (-68.08%), greater than Harpoon Therapeutics, Inc. (-19.66%), greater than Alector, Inc. (-108.77%),

Build a custom stock screener for Atreca, Inc. (BCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atreca, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atreca, Inc. (BCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atreca, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Atreca, Inc.'s ROE?

How is the ROE calculated for Atreca, Inc. (BCEL)?

What is the highest ROE for Atreca, Inc. (BCEL)?

What is the 3-year average ROE for Atreca, Inc. (BCEL)?

What is the 5-year average ROE for Atreca, Inc. (BCEL)?

How does the current ROE for Atreca, Inc. (BCEL) compare to its historical average?